Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

VASCULAR DEMENTIA 2020

About Conference


Neuroscience conferences is inviting you to“2nd World Conference on Vascular Dementia & Movement Disorders” during August 26-27, 2020, at Singapore.

Vascular dementia is a general term describing problems with reasoning, planning, judgment, memory and other thought processes caused by brain damage from impaired blood flow to your brain.

Causes of Vascular Dementia: Vascular dementia occurs when vessels that supply blood to the brain become blocked or narrowed. Strokes take place when the supply of blood carrying oxygen to the brain is suddenly cut off. However, not all people with stroke will develop vascular dementia.

Factors that increase your risk of heart disease and stroke — including diabetes, high blood pressure, high cholesterol and smoking. Controlling these factors may help lower your chances of developing vascular dementia

Vascular dementia is the second-most-common type of dementia in the United States and Europe in the elderly; however it is the most common form in some parts of Asia. The incidence of the illness is 1.5% in Western countries and just about 2.2% in Japan. It accounts for 50% of all dementias in Japan, 20% to 40% in Europe and 15% in Latin America. The prevalence of dementia is 9 times higher in patients who have had a stroke than in controls. 25% of stroke patients develop new-onset dementia within 1 year of their stroke. The relative risk of incident dementia is 5.5% within 4 years of suffering a stroke.

Benefits of attending!

 Benefits to Attend Vascular Dementia 2020

  • Learning in a New Space
  • Learning with the experts
  • Novel techniques to benefit your research
  • Lectures by active practitioners
  • Networking with new people within your field
  • Keynote forums by Prominent Professors, Doctors and Physicians
  • Poster presentations by Young Researchers
  • Learning about facts and statistics to better understand the market and industry

Target Audience:

  • Business ambassadors
  • Industrial Frontrunners
  • Stroke Scientists, Neuro Oncologists
  • CEO's and Directors
  • Neurologist
  • Neurosurgeons
  • Psychiatrist
  • Neuroscientist
  • Head of department
  • Professors and Students from Academia in the research of neurological disorders

 

 

Sessions And Tracks

Dementia

Dementia is a wide category of brain diseases that cause an abiding and often moderate decrease in the capability to think and recall that is acute enough to affect a person's normal functioning. The most usual category of dementia is Alzheimer's disease, which makes up 50% to 70% of cases. The indications of dementia differ across types and stages of the diagnosis. The most usual affected areas are memory, visual-spatial, problem solving, language and attention. There is no known treatment for dementia. Cholinesterase inhibitors such as donepezil are frequently used and may be beneficial in moderate disorder.

Vascular Dementia and Stroke

Vascular dementia is dementia caused by difficulty in the supply of blood to the brain, typically a series of minor strokes, leading to worsening cognitive decline that occurs step by step. The term refers to a syndrome consisting of a complex interaction of cerebrovascular disease and risk factors that lead to changes in the brain structures due to strokes and lesions, and resulting changes in cognition. The temporal relationship between a stroke and cognitive deficits is needed to make the diagnosis. People with vascular dementia present with progressive cognitive impairment, acutely or sub acutely as in mild cognitive impairment, frequently step-wise, after multiple cerebrovascular events (strokes).

Amyloid Imaging in Dementia

Amyloid-related imaging abnormalities (ARIA) are abnormal differences seen in neuroimaging of Alzheimer's disease patients, associated with amyloid-modifying therapies, particularly human monoclonal antibodies such as aducanumab. There are two types of ARIA - ARIA-E and ARIA-H. The phenomenon was first seen in trials of bapineuzumab.

Alzheimer’s disease

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and gradually worsens over time. It is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events. As the disease advances, symptoms can include problems with language, disorientation (including easily getting lost), mood swings, and loss of motivation, not managing self-care, and behavioral issues. As a person's condition declines, they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death

Neurodegenerative Diseases

Neuro degeneration is the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative diseases – including amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, and Huntington's disease – occur as a result of neurodegenerative processes. Such diseases are incurable, resulting in progressive degeneration and/or death of neuron cells. As research progresses, many similarities appear that relate these diseases to one another on a sub-cellular level. Discovering these similarities offers hope for therapeutic advances that could ameliorate many diseases simultaneously

Brain Diseases

Central nervous system problems are also known as central nervous system disorders. These are the neurological problems that affect the function and structure of the brain and spinal cord, which form the central nervous system. Signs are like persistent headache; face pain, band and legs pain, inability to concentrate and slurred speech etc.

Ageing and Dementia

Aging is a main risk element for most common neurodegenerative problems, including mild cognitive impairment, dementias including cerebrovascular disease, Alzheimer's disease, Lou Gehrig's disease, and Parkinson's disease. While much research has focused on problems of aging, there are less informative studies on the molecular biology of the aging brain in the lack of neurodegenerative disease or the neuropsychological discription of healthy older adults. However, research suggests that the aging process is associated with several structural, chemical, and functional changes in the brain as well as a host of neurocognitive changes.

Dementia Care Management

Dementia care management is nothing but care provided to dementia patients at home/hospital. In-home care includes a wide range of services provided in the home, rather than in a hospital or care facility. It can allow a person with Alzheimer's or other dementia to stay in his or her own home. It also can be of great assistance to caregivers. It can allow a person with Alzheimer's or other dementia to stay in his or her own home.

Dementia Nursing

Dementia nurses can provide treatment, support and care for people with dementia and mental health problems. They might assess you at your home, and they advise you and your careers on ways of improving your health and quality of life. Dementia nurses do not normally carry out physical tasks like changing bandages or keeping saline etc. Dementia nurses will do psychological activities to care dementia patients.

Diagnosis and treating Dementia

Diagnosing dementia and its categories can be challenging. People have dementia when they have analytical impairment and lose their capability to do daily functions, such as driving safely, taking medications, taking food time on time etc. To diagnose the reason of dementia, the physician must recognize the pattern of the dropping of skills, function and understand what a person is still capable to do. Recently, biomarkers are available to make a more exact diagnosis of Alzheimer's problem. Doctor will examine your medical condition, history, symptoms and conduct a physical/mental examination.

Neuropharmacology

Neuropharmacology will give information about how drugs affect cellular function in the nervous system, and the neural mechanisms through which they influence behavior. There are two main branches of neuropharmacology: behavioral and molecular. Behavioral neuropharmacology focuses on the study of how drugs affect human behavior (neuro psychopharmacology), including the study of how drug dependence and addiction affect the human brain.  Molecular neuropharmacology involves the study of neurons and their neurochemical interactions, with the overall goal of developing drugs that have beneficial effects on neurological function.

Novel therapeutics for Dementia:

Novel Therapeutic Technology is a leading pioneer in the development of sophisticated and practical drug delivery systems. NTT's Ethosome technology provides the means to significantly enhance drug penetration of topical delivery applications, exponentially increasing therapeutic efficiency. With worldwide recognized drugs combined with NTT know-how, Pharmaceutical companies are able to introduce new and better drugs to the market, thus greatly reducing side effects, improving patient compliance, and increasing the patient’s quality of life.

Neuro Oncology and CNS:

It is a branch of Medical Sciences majorly deals with Neuro tumors. Deals with Studies related to Brain and Spinal cord neoplasms. Neuro-oncology and Pediatric Neuro-oncology are the two different Concepts that differentiate the determining methodology of Neuro tumors. Neuro-oncology mainly includes especially related topics like Radiation therapy, Neurosurgery, Neuroimaging, social, Psychological, Neuropathology and psychiatric aspects.

Related Conferences: 14th International Conference on Alzheimers Disease & Dementia October 12-13, 2020 Zurich, Switzerland, Vascular Dementia and Neurodegenerative Diseases, May 18-19, 2020 Osaka, Japan, 13th International Conference onDementia and Vascular Dementia June 24-25, 2020 Zurich, Switzerland12th International Conference on Vascular Dementia June 22-23, 2020 Prague, Czech Republic, Dementia, Alzheimers and Neurological Disorders May 07-08, 2020 Zagreb, Croatia,16th International Conference and Exhibition on Alzheimers Disease, Dementia & Ageing April 13-14, 2020, London, UK.

Related Societies and Associations: Alzheimer’s SocietyDementia Society of AmericaAlzheimer's AssociationDementia Australia, Alzheimer's Disease InternationalAlzheimer Society of Ireland, Alzheimer Society of Toronto, American Stroke Association, Alzheimer's Research UKSocial care institute for excellenceFraser HealthCalderdale Council.

Market Analysis

The global market for treatments of syndromes like dementia and movement disorders was valued at 10.5 billion in 2011 and was estimated to reach $11.1 billion in 2012. Total market value is expected to reach $16.7 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 8.5%.

Someone in the world develops dementia every 3 seconds. There were an estimated 46.8 million people worldwide living with dementia in 2015 and this number is believed to be close to 50 million people in 2017. These numbers will almost double every 20 years, reaching 75 million in 2030 and 131.5 million in 2050. Much of the increase will be in developing countries. Already 58% of people with dementia live in low and middle income countries, but by 2050 this will rise to 68%. The fastest growth in the elderly population is taking place in China, India, and their south Asian and western Pacific neighbours.

Major Neuroscience Societies and Associations in Singapore:

Singapore Neuro Science Association

National Neuroscience Institute

Neurology Asia

Asian-Pacific Society for Neurochemistry

Clinical Neuroscience Society Singapore

Child Neurology Society


Major Dementia and Alzheimer’s Societies and Associations around Globe:

Alzheimer's Australia

Hilarescere Foundation in Italy

Alzheimer Society of Bangladesh

Alzheimer Support Group

Alzheimer's Association

Southern Clinical Neurological Society

American Academy of Neurology

ESNR European Society of Neuroradiology

European Neurological Societies

Alzheimer Austria

Foundation Alzheimer Aruba (FAA)

Alzheimer's disease Chinese

Spanish Society of Neurology

Alzheimer's Society

Major Neurological Associations in Italy

British brain tumor association


Top Neuroscience Universities in Singapore:

National Neuroscience Institute

Cognitive Neuroscience Lab

National University of Singapore

National Institute of Education

Nanyang Technological University

Singapore Neurology and Sleep Center

Duke–NUS Medical School

Devathasan Neurology & Medical Pte Ltd

National University Health System

Singapore Management University


Top Neuroscience Universities in Globe:

Dalhousie University

University of Nottingham

Leiden University

Cardiff University

Temple University USA

University of Toronto

University Oklahoma

University Sheffield

University of Bristol

University California

Florida International University

University of Amsterdam

University of Edinburgh

Karolinska Institute

University of Milan

University of Gothenburg


Hospital Associated with Dementia:

SBCC Baby & Child Clinic (Neurology Centre)

Tang Neurology & Medical Clinic

Vision 2 Engineering Pte. Ltd

Raffles Neuroscience Centre

P N Chong Neurology Clinic

Mount Elizabeth Hospital

Tan Chai Beng

Dr Adrian Tan Keng Yew

Ho Neurology Pte Ltd

Gleneagles Hospital

National Neuroscience Institute

National University Hospital


Companies Associated with Dementia in Singapore

iNova Pharmaceuticals (Singapore) Pte. Limited

Johnson & Johnson

Medicell Pharmaceutical (S) Pte. Ltd

West Pharmaceutical

GSK Quality Road

Merck Pte Ltd

GSK Jurong

Poli Medical Company Pte Ltd


Top Dementia Companies:

Brainomix

Polyneuron Pharmaceuticals AG Corp.

reHaptix GmbH

Biogen Idec

KB Medical

Intento SA

OncoVision

AcelRx Pharmaceuticals, Inc.

Trevena

AcelRx Pharmaceuticals, Inc.

Mintlabs

Mylan

Actavis

Bayer

Lundbeck

Novartis


References:

  • http://www.alzheimers.org.uk/dementiauk
  • https://en.wikipedia.org/wiki/Alzheimer's_Research_UK
  • http://www.alzheimersresearchuk.org/
  • http://www.alz.org/uk/dementia-alzheimers-uk.asp
  • http://www.alzheimersresearchuk.org/about-dementia/facts-stats/
  • http://www.alz.org/research/funding/alzheimers_our_commitment.asp
  • https://www.ucl.ac.uk/dementia
  • http://www.city.ac.uk/courses/cpd/evidence-based-dementia-care
  • http://www.kcl.ac.uk/ioppn/depts/oldage/research/bdr.aspx

To Collaborate Scientific Professionals around the World

Conference Date August 26-27, 2020

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Journal of Neurological Disorders Journal of Neurology and Neuroscience Journal of Alzheimers Disease & Parkinsonism

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Keytopics

  • 2-Dimensional Transthoracic Echocardiography
  • Abdominal Aorta
  • Abdominal Obesity
  • Ablation
  • Accelerated Atherosclerosis
  • Acquired Heart Disease
  • Advance Drug For Dementia
  • Ageing And Dementia
  • Alveoli
  • Alzheimers Disease
  • Amiodarone
  • Amyloid Imaging In Dementia
  • Aneurysm
  • Aneurysmorrhapy
  • Angina Or Angina Pectoris
  • Angiography
  • Angioplasty
  • Angiotensin II Receptor Blocker
  • Annulus
  • Antiarrhythmics
  • Behavioral Risk Factors
  • Biscuspid Aortic Valve
  • Blood Investigations
  • Blood Pressure Control
  • Blunt Chest Trauma
  • Bradycardia
  • Brain
  • Brain Diseases
  • Cardiac Abnormalities
  • Cardiac Arrest
  • Cardiac Biomarkers
  • Cardiac Hypertrophy
  • Cardiac Lipomas
  • Cardiac Mapping
  • Cardiac Nursing And Healthcare
  • Cardiac Outpu
  • Cardiac Regeneration
  • Cardiac Sarcoidosis
  • Cardiac Stroke
  • Cardiac Troponin Assay
  • Cardio-Fix-Occluder
  • Cardio-protection
  • Cardiology And Cardiovascular Therapeutics
  • Cardiometabolic Disorder
  • Cardiomyopathy
  • Cardiovascular (CV) Involvement
  • Cardiovascular Autonomic Reactivity
  • Cardiovascular Disease
  • Cardiovascular Disease (CVD)
  • Cardiovascular Disease Risk Factor
  • Cardiovascular Diseases
  • Cardiovascular Diseases
  • Cardiovascular Risk
  • Cardiovascular Risk Factors
  • Cardiovascular Surgeries
  • Cardiovascular Surgery
  • Carotid Angiography
  • Carotid Artery Stenosis
  • Carotid Intima-medial Thickness
  • Clinical Cardiology
  • Coronary Artery Disease
  • Critical Cardiac Care
  • Dementia
  • Dementia Care Management
  • Dementia Nursing
  • Heart And Obesity
  • Heart Diseases
  • Heart Failure
  • Heart Rate
  • Hypertension
  • Infectious Endocarditis
  • Interventional Cardiology
  • Lewy Body Dementia
  • Metabolic Syndrome X
  • Myocardial And Pericardial Disease
  • Myocardial Infarction
  • Neuro Oncology And CNS
  • Neurodegenerative Diseases
  • Neuropharmacology
  • Novel Therapeutics
  • Obesity
  • Open Surgery
  • Oral Anticoagulant
  • Orthodeoxia
  • Pericardial Closure
  • Pericardiocentesis
  • Primary Prevention
  • Risk Factors
  • Stroke
  • Treating Dementia
  • Vascular Dementia And Stroke
  • Vascular Diseases
  • Vascular Endothelial Growth Factor
  • Vascular Heart Disease
  • CausesandPrevention Of Dementia